164 related articles for article (PubMed ID: 10231374)
1. Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization.
Hoover DM; Schalk-Hihi C; Chou CC; Menon S; Wlodawer A; Zdanov A
Eur J Biochem; 1999 May; 262(1):134-41. PubMed ID: 10231374
[TBL] [Abstract][Full Text] [Related]
2. Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.
Yoon SI; Jones BC; Logsdon NJ; Walter MR
Structure; 2005 Apr; 13(4):551-64. PubMed ID: 15837194
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1.
Jones BC; Logsdon NJ; Josephson K; Cook J; Barry PA; Walter MR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9404-9. PubMed ID: 12093920
[TBL] [Abstract][Full Text] [Related]
4. Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1.
Josephson K; McPherson DT; Walter MR
Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1908-11. PubMed ID: 11717514
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.
Josephson K; Logsdon NJ; Walter MR
Immunity; 2001 Jul; 15(1):35-46. PubMed ID: 11485736
[TBL] [Abstract][Full Text] [Related]
6. A model of the ternary complex of interleukin-10 with its soluble receptors.
Pletnev S; Magracheva E; Wlodawer A; Zdanov A
BMC Struct Biol; 2005 Jun; 5():10. PubMed ID: 15985167
[TBL] [Abstract][Full Text] [Related]
7. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5.
Devos R; Guisez Y; Cornelis S; Verhee A; Van der Heyden J; Manneberg M; Lahm HW; Fiers W; Tavernier J; Plaetinck G
J Biol Chem; 1993 Mar; 268(9):6581-7. PubMed ID: 8454628
[TBL] [Abstract][Full Text] [Related]
8. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
[TBL] [Abstract][Full Text] [Related]
9. Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography.
Josephson K; Jones BC; Walter LJ; DiGiacomo R; Indelicato SR; Walter MR
Structure; 2002 Jul; 10(7):981-7. PubMed ID: 12121653
[TBL] [Abstract][Full Text] [Related]
10. Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes.
Jog NR; Chakravarty EF; Guthridge JM; James JA
Front Immunol; 2018; 9():2198. PubMed ID: 30356670
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties.
Yoon SI; Jones BC; Logsdon NJ; Harris BD; Kuruganti S; Walter MR
J Biol Chem; 2012 Aug; 287(32):26586-95. PubMed ID: 22692218
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20.
Pletnev S; Magracheva E; Kozlov S; Tobin G; Kotenko SV; Wlodawer A; Zdanov A
Biochemistry; 2003 Nov; 42(43):12617-24. PubMed ID: 14580208
[TBL] [Abstract][Full Text] [Related]
13. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation.
Ding Y; Qin L; Zamarin D; Kotenko SV; Pestka S; Moore KW; Bromberg JS
J Immunol; 2001 Dec; 167(12):6884-92. PubMed ID: 11739506
[TBL] [Abstract][Full Text] [Related]
14. Comparison of interleukin-22 and interleukin-10 soluble receptor complexes.
Logsdon NJ; Jones BC; Josephson K; Cook J; Walter MR
J Interferon Cytokine Res; 2002 Nov; 22(11):1099-112. PubMed ID: 12513909
[TBL] [Abstract][Full Text] [Related]
15. Structure of interleukin-10/interleukin-10R1 complex: a paradigm for class 2 cytokine activation.
Walter MR
Immunol Res; 2002; 26(1-3):303-8. PubMed ID: 12403368
[TBL] [Abstract][Full Text] [Related]
16. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S
Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991
[TBL] [Abstract][Full Text] [Related]
17. High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.
Salek-Ardakani S; Stuart AD; Arrand JE; Lyons S; Arrand JR; Mackett M
Cytokine; 2002 Jan; 17(1):1-13. PubMed ID: 11886166
[TBL] [Abstract][Full Text] [Related]
18. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
19. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
20. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
